* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
JSC Georgia Healthcare Group is the healthcare-services (hospitals and clinics) business of Georgia Capital PLC (LSE: CGEO) — Georgia's largest integrated healthcare provider. It was established in Georgia Capital's 2024 reorganization to hold the hospital/clinic operations carved out of the former GHG (e.g. JSC Georgian Clinics, JSC Viani), while the pharmacy business stayed with the renamed Georgia Pharmacy Group (id 405098399). It runs about 7 large and specialty hospitals, ~30 regional and community hospitals, 16 EVEX polyclinics and the Mega Lab diagnostics laboratory (~2,460 beds), and acquired Gormed LLC (three regional hospitals and clinics) in December 2025. The GHG healthcare business was LSE-listed until Georgia Capital took it private in August 2020.
| Line item | 2024 |
|---|---|
| Total Revenue | 400,233 |
| Total COGS | 247,541 |
| Gross Profit | 152,692 |
| Gross Margin | 38.2% |
| Other Operating Income | 10,608 |
| 89,599 | |
| EBITDA | 73,701 |
| EBITDA Margin | 18.4% |
| Total D&A | 44,174 |
| EBIT / Operating Income | 29,527 |
| Total Interest Income | 925 |
| Total Interest Expense | 37,080 |
| 5,679 | |
| Profit Before Tax | 12,307 |
| Total Income Tax | 0 |
| Net Profit / (Loss) | 12,307 |
| Net Margin | 3.1% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →